At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FOXO FOXO Technologies
Pre-Market Trading 01-24 06:59:16 EST
0.2665
-0.0035
-1.30%
盘前0.2570
-0.0095-3.56%
06:13 EST
High0.3004
Low0.2515
Vol7.45M
Open0.2673
D1 Closing0.2700
Amplitude18.11%
Mkt Cap6.28M
Tradable Cap5.70M
Total Shares23.57M
T/O2.04M
T/O Rate34.80%
Tradable Shares21.40M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
FOXO Technologies Special Shareholder Meeting Announcement
Foxo Technologies Inc. Announces That Stockholders Equity Is Greater Than $4M, Which Is Required to Meet the Continued Listing Requirements of the Nyse American Exchange
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.